BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30281242)

  • 1. [Frequency and nature of drug related problems with corticosteroids in Belgian community pharmacies].
    Lelubre M; Koubaity M; De Wulf I; Boussery K; De Meyer GRY; Foulon V; Lacour V; Steurbaut S; Van Hees T; Amighi K; Bugnon O; De Vriese C
    J Pharm Belg; 2016 Sep; (3):32-41. PubMed ID: 30281242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacists' role in handling problems with prescriptions for antithrombotic medication in Belgian community pharmacies.
    Desmaele S; De Wulf I; Dupont AG; Steurbaut S
    Int J Clin Pharm; 2015 Aug; 37(4):656-68. PubMed ID: 25822042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studying the impact of a medication use evaluation by the community pharmacist (Simenon): Drug-related problems and associated variables.
    Wuyts J; Maesschalck J; De Wulf I; Lelubre M; Foubert K; De Vriese C; Boussery K; Goderis G; De Lepeleire J; Foulon V
    Res Social Adm Pharm; 2020 Aug; 16(8):1100-1110. PubMed ID: 31759887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of drug-related problems with new prescriptions using a modified PCNE classification system.
    Eichenberger PM; Lampert ML; Kahmann IV; van Mil JW; Hersberger KE
    Pharm World Sci; 2010 Jun; 32(3):362-72. PubMed ID: 20229029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug related problems in Belgian community pharmacies].
    Huysmans K; De Wulf I; Foulon V; De Loof H; Steurbaut S; Boussery K; De Vriese C; Lacour V; Van Hees T; De Meyer GR
    J Pharm Belg; 2014 Mar; (1):4-15. PubMed ID: 24804389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptation and validation of PCNE drug-related problem classification v6.2 in French-speaking Belgian community pharmacies.
    Koubaity M; Lelubre M; Sansterre G; Amighi K; De Vriese C
    Int J Clin Pharm; 2019 Feb; 41(1):244-250. PubMed ID: 30610541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-related problems detected in Australian Community Pharmacies: The PROMISe Trial.
    Williams M; Peterson GM; Tenni PC; Bindoff IK; Curtain C; Hughes J; Bereznicki LR; Jackson SL; Kong DC; Hughes JD
    Ann Pharmacother; 2011 Sep; 45(9):1067-76. PubMed ID: 21878658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug related problems identified by European community pharmacists in patients discharged from hospital.
    Paulino EI; Bouvy ML; Gastelurrutia MA; Guerreiro M; Buurma H;
    Pharm World Sci; 2004 Dec; 26(6):353-60. PubMed ID: 15683106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical evaluation of the drug-related problem management process in Swiss community pharmacies.
    Krähenbühl JM; Kremer B; Guignard B; Bugnon O
    Pharm World Sci; 2008 Dec; 30(6):777-86. PubMed ID: 18392732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
    Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
    Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of drug-related problems identified by community pharmacies.
    Hämmerlein A; Griese N; Schulz M
    Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: a pilot study.
    Szilvay A; Somogyi O; Meskó A; Zelkó R; Hankó B
    BMC Health Serv Res; 2019 May; 19(1):282. PubMed ID: 31053135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication review in German community pharmacies - Post-hoc analysis of documented drug-related problems and subsequent interventions in the ATHINA-project.
    Seidling HM; Send AFJ; Bittmann J; Renner K; Dewald B; Lange D; Bruckner T; Haefeli WE
    Res Social Adm Pharm; 2017 Nov; 13(6):1127-1134. PubMed ID: 27816566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of the Slovenian drug-related problem classification system based on the PCNE classification V 6.2.
    Horvat N; Kos M
    Int J Clin Pharm; 2016 Aug; 38(4):950-9. PubMed ID: 27255777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of drug-related problems among hospitalized ischemic stroke patients in China.
    Chen Q; Jin Z; Zhang P; Sun S; Li L; Liao Y
    Int J Clin Pharm; 2020 Aug; 42(4):1237-1241. PubMed ID: 32607718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-related problems among hospitalized cancer pain patients: an investigative single-arm intervention trial.
    Su YJ; Yan YD; Wang WJ; Xu T; Gu ZC; Bai YR; Lin HW
    Ann Palliat Med; 2021 Feb; 10(2):2008-2017. PubMed ID: 33353357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and solution of drug-related problems in the neurology unit of a tertiary hospital in China.
    Liu P; Li G; Han M; Zhang C
    BMC Pharmacol Toxicol; 2021 Oct; 22(1):65. PubMed ID: 34702348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical care in community pharmacies: practice and research in Sweden.
    Westerlund LT; Björk HT
    Ann Pharmacother; 2006 Jun; 40(6):1162-9. PubMed ID: 16735653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Documentation of drug related problems and their management in community pharmacy: Data evolution over six years.
    Amador-Fernández N; Baechler T; Quintana-Bárcena P; Berger J
    Res Social Adm Pharm; 2023 Nov; 19(11):1480-1485. PubMed ID: 37481352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DOCUMENT: a system for classifying drug-related problems in community pharmacy.
    Williams M; Peterson GM; Tenni PC; Bindoff IK; Stafford AC
    Int J Clin Pharm; 2012 Feb; 34(1):43-52. PubMed ID: 22101425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.